Javascript must be enabled to continue!
Patient Reported Outcomes Following Knee Arthroscopy
View through CrossRef
Objective: To assess the patient reported outcomes following therapeutic knee arthroscopy for AnteriorCruciate Ligament tear among patients aged 18 years to 65 years undergoing first surgery on affected kneeusing the Lysholm knee score and visual Analog Scale for pain pre-operatively and post-operatively at 6weeks follow up.Material and Methods: A descriptive case series was conducted at Orthopedics department, Gulab DeviHospital, Lahore from November 2025 to January 2026. A non-probability consecutive sampling techniquewas employed. The sample comprised of 50 patients with knee pain due to isolated anterior cruciate ligamentinjury. After taking informed consent, data was collected on Lysholm knee score and Visual Analog Scaleforms pre-operatively and post-operatively at 6 weeks of follow up. Statistical analysis was conducted usingthe SPSS version 26.Results: The mean age of patients included in the study was 28.6 ±6.4 years. Data of 50 patients who weresuffering from anterior cruciate ligament tear was collected. The mean Lysholm Knee score improved from64.8 pre-operatively to 94.2 and the visual analog scale for pain decreased from 4.98 to 0.18 at 6 weeks postoperatively.The p-value for Lysholm Knee score and Visual Analog Scale were both ≤ 0.001, showing asignificant improvement in knee function and pain levels perceived by the patient.Conclusion: Patients suffering from anterior cruciate ligament injury had improved outcomes of kneefunction and pain levels following therapeutic knee arthroscopy at 6 weeks follow up.Keywords: therapeutic knee arthroscopy, patient reported outcomes, Lysholm score and visual analog scaleHow to cite: Kazi AS, Bilal M, Saeed KM. Patient Reported Outcomes Following Knee Arthroscopy. Esculapio -JSIMS 2025;22(01):DOI: 10.51273/esculap.v22i01.1541
Services Institute of Medical Sciences, Lahore
Title: Patient Reported Outcomes Following Knee Arthroscopy
Description:
Objective: To assess the patient reported outcomes following therapeutic knee arthroscopy for AnteriorCruciate Ligament tear among patients aged 18 years to 65 years undergoing first surgery on affected kneeusing the Lysholm knee score and visual Analog Scale for pain pre-operatively and post-operatively at 6weeks follow up.
Material and Methods: A descriptive case series was conducted at Orthopedics department, Gulab DeviHospital, Lahore from November 2025 to January 2026.
A non-probability consecutive sampling techniquewas employed.
The sample comprised of 50 patients with knee pain due to isolated anterior cruciate ligamentinjury.
After taking informed consent, data was collected on Lysholm knee score and Visual Analog Scaleforms pre-operatively and post-operatively at 6 weeks of follow up.
Statistical analysis was conducted usingthe SPSS version 26.
Results: The mean age of patients included in the study was 28.
6 ±6.
4 years.
Data of 50 patients who weresuffering from anterior cruciate ligament tear was collected.
The mean Lysholm Knee score improved from64.
8 pre-operatively to 94.
2 and the visual analog scale for pain decreased from 4.
98 to 0.
18 at 6 weeks postoperatively.
The p-value for Lysholm Knee score and Visual Analog Scale were both ≤ 0.
001, showing asignificant improvement in knee function and pain levels perceived by the patient.
Conclusion: Patients suffering from anterior cruciate ligament injury had improved outcomes of kneefunction and pain levels following therapeutic knee arthroscopy at 6 weeks follow up.
Keywords: therapeutic knee arthroscopy, patient reported outcomes, Lysholm score and visual analog scaleHow to cite: Kazi AS, Bilal M, Saeed KM.
Patient Reported Outcomes Following Knee Arthroscopy.
Esculapio -JSIMS 2025;22(01):DOI: 10.
51273/esculap.
v22i01.
1541.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Knee Arthroscopy Simulation
Knee Arthroscopy Simulation
Background:
Virtual-reality and cadaveric simulations are expensive and not readily accessible. Innovative and accessible training adjuncts are required to help to meet...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Evaluating the compatibility between magnetic resonance imaging (MRI) and arthroscopy in diagnosis of anterior cruciate ligament injury
Evaluating the compatibility between magnetic resonance imaging (MRI) and arthroscopy in diagnosis of anterior cruciate ligament injury
Introduction: This research aims to evaluate the compatibility between magnetic resonance imaging (MRI) and arthroscopy in diagnosis of types and locations of anterior cruciate lig...
Hip Arthroscopy Surgical Volume Trends and 30‐Day Postoperative Complications
Hip Arthroscopy Surgical Volume Trends and 30‐Day Postoperative Complications
Purpose
To determine hip arthroscopy surgical volume trends from 2006 to 2013 using the National Surgical Quality Improvement Program (NSQIP) database, the inci...
Basic Knee Arthroscopy Part 3: Diagnostic Arthroscopy
Basic Knee Arthroscopy Part 3: Diagnostic Arthroscopy
Abstract
Knee arthroscopy is an important diagnostic and therapeutic tool in the management of disorders of the knee. In...
Level of knee functional limitations among patients after knee arthroscopy: a cross-sectional study
Level of knee functional limitations among patients after knee arthroscopy: a cross-sectional study
Abstract
Introduction
Knee joint disorders are prevalent musculoskeletal conditions that frequently impair daily function...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

